Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Guess Stock Faces Critical Earnings Test

Dieter Jaworski by Dieter Jaworski
November 18, 2025
in Analysis, Consumer & Luxury, Earnings
0
Guess ? Stock
0
SHARES
109
VIEWS
Share on FacebookShare on Twitter

Fashion retailer Guess finds itself at a pivotal moment as it prepares to release third-quarter 2026 financial results this Tuesday. The upcoming earnings report arrives amid conflicting signals from market professionals and institutional investors, creating significant anticipation around the announcement.

Wall Street’s Cautious Stance

Market experts maintain a restrained outlook toward Guess shares despite the company’s recent performance. Currently, all five covering analysts unanimously recommend a “Hold” position on the stock. Their average price target sits at $16.75, slightly below the current trading level of $16.92.

Recent analyst actions underscore this cautious sentiment. Zacks Research downgraded the equity from “Strong Buy” to “Hold” just days ago, while Weiss Ratings affirmed its “Hold” recommendation in October. This consistent positioning suggests professionals await stronger evidence of sustained performance before becoming more bullish.

Previous Quarter Exceeded Expectations

The company’s most recent financial disclosure demonstrated impressive strength. In late August, Guess reported earnings of $0.26 per share, significantly surpassing the $0.16 consensus estimate. Revenue reached $772.94 million, exceeding the projected $758.72 million and representing a 5.5% year-over-year increase.

Should investors sell immediately? Or is it worth buying Guess ??

This positive surprise sets a challenging benchmark for the upcoming report, where analysts project earnings of $0.23 per share on revenue of $767.9 million.

Institutional Money Flows Tell Different Story

Contrasting with analyst skepticism, institutional investors have demonstrated growing interest in Guess:

  • Corient Private Wealth LLC established a $205,000 position during the second quarter
  • Quadrant Capital Group LLC initiated a $136,000 investment in the third quarter
  • Both Brown Advisory Inc. and Cerity Partners LLC entered positions in Q2 with investments of $128,000 and $134,000 respectively

This institutional accumulation creates an intriguing dynamic where professional money managers appear more confident than research analysts.

The fashion company’s shares now trade at the intersection of these conflicting perspectives. Tuesday’s earnings release will determine whether the cautious analysts or optimistic institutions have correctly assessed Guess’s trajectory.

Ad

Guess ? Stock: Buy or Sell?! New Guess ? Analysis from March 25 delivers the answer:

The latest Guess ? figures speak for themselves: Urgent action needed for Guess ? investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Guess ?: Buy or sell? Read more here...

Tags: Guess ?
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Next Post
Altria Stock

Altria Faces Mounting Pressure in US Oral Tobacco Market

Almonty Stock

Almonty Secures Strategic Foothold in US Critical Minerals Market

Omv Stock

OMV Shares Face Conflicting Signals as Management and Analysts Clash

Recommended

Banner Stock

All Eyes on Fed as Banner Corporation Awaits Rate Decision

6 months ago
Dynatrace Holdings LLC Stock

Dynatrace Holdings LLC Stock: Strong Q1 Performance Beats Expectations

8 months ago
MP Materials Stock

MP Materials: Record Production Amid Financial Headwinds

4 months ago
Omv Stock

OMV Faces Critical Juncture as Qatar Threatens European Gas Supplies

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Trending

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

by Jackson Burston
March 25, 2026
0

Fair Isaac Corporation, the company behind the ubiquitous FICO credit score, is facing a dual-pronged assault that...

Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem
  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com